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In Short
The article details how Professor Bartlett realised his vision of creating a unique scientific environment in which to discover 
the fundamental mechanisms that regulate brain functions like learning and memory through the formation of the Queen-
sland Brain Institute (QBI). The establishment of the QBI came about through the prescient support of philanthropist Chuck 
Feeney, Queensland Premiers Beattie and Bligh and The University of Queensland Vice Chancellor John Hay. This under-
pinned the ability to recruit a team of outstanding neuroscientists from around the world and around Australia and ensured 
the QBI was equipped with state of the art technologies. Although, the QBI has been in its new building for three years, the 
success of the venture already is evident by its peerless grant and fellowship success, and its output of highly cited publica-
tions positioning it as a pre-eminent neuroscience research institute within the Asia-Pacific region.
As the founding Director of the Queensland Brain Institute (QBI), my vision was to create a unique environment in which outstanding neuroscientists working across a range of sub-disciplines and 
animal models could interact and collaborate to discover the fundamental mechanisms regulating brain 
function in health (learning, memory, attention) and disease (developmental and neurodegenerative 
disorders, mental illness). My raison d’être for this was the belief that a deeper understanding of these 
mechanisms would create the opportunity to develop novel therapeutic approaches to address the tidal 
wave of neurological and mental illness in our community. Furthermore, I was convinced that the ap-
plication of discoveries about learning, memory, and attention would provide the basis for radically 
improved outcomes in academic and occupational education, from childhood to old age, through the 
development of a new discipline, the ‘science of learning.’ In addition, understanding of sensory and 
motor systems provided the potential to develop a variety of rehabilitation strategies, robotic sensors 
and even in-flight guidance systems for unmanned vehicles.
 However all of the above advances would rely on elucidating how nerve cells in the central 
nervous system were able to respond and adapt to changes in external stimulation by changing their 
pattern of connections (synapses)—a process known as brain plasticity. Thus brain plasticity in its many 
forms became the centrepiece of our research endeavours, being both the primary determinant of brain 
function as well as offering the malleability to promote repair following disease, injury or even the 
effects of normal ageing.
 Recruitment of researchers to QBI was based on this concept, beginning with a cohort of neuro-
scientists interested in the cellular plasticity generated by new neuronal production. These included 
members of my own group and those of Dr. Elizabeth Coulson and Dr. Rodney Rietze, who transferred 
from the Walter and Eliza Hall Institute (WEHI) in Melbourne, as well as Professor Brent Reynolds, 
the co-discoverer, with my research group, of neuronal stem cells in the adult brain, who joined us 
from Canada. The drive to understand synaptic plasticity was initially spearheaded by Professor Pankaj 
Sah’s group from the John Curtin School of Medical Research at the Australian National University 
(ANU) in Canberra. However this cohort has since been expanded by the inclusion of a number of 
outstanding UQ neuroscientists (Professors Joseph Lynch and David Adams and Associate Professor 
Frederic Meunier), as well as Associate Professor Stephen Williams, who has recently joined us from 
the University of Cambridge. Linking electrophysiology-based research with cellular- and molecular-
based studies has proven a major success, most notably leading to discoveries about how learning and 
memory are regulated in two key regions of the brain, the hippocampus and the amygdala. This work 
was driven in part by a major five year NHMRC Programme Grant to myself and Pankaj Sah, the only 
such grant to be funded to investigate basic neuroscience. This work is now continuing with our second 
NHMRC Programme Grant, which commenced in 2009.
 Axonal guidance was another key area of plasticity research, spearheaded by the recruitment 
of Professors Linda Richards and Geoffrey Goodhill from the USA, together with Associate Professor 
Helen Cooper from WEHI More recently, Dr. Massimo Hilliard from Rockefeller University has estab-
lished a laboratory using the nematode C. elegans as a model. Together, these scientists have made major 
discoveries regarding the molecular guidance of axons, a process that is essential for the correct wiring 
of the nervous system. In a related line of investigation, work from my own laboratory has identified 
the importance of the molecule EphA4 in preventing the regrowth of injured axons, with therapeutics 
designed to block its deleterious effects nearing clinical trial for the treatment of spinal cord injury.
 Having established this nucleus of researchers, the next phase of recruitment centred on devel-
oping a system-wide understanding of these regulatory processes by focusing on the whole animal. 
In this regard, we have taken an eclectic approach in our choice of animal models, which range from 
the fruit fly Drosophila and the honeybee through C. elegans, to rodents and ultimately humans, in the 
belief that each offers particular but complementary advantages. We have recruited a very high profile 
group of scientists to lead these studies: Associate Professor Bruno van Swinderen from the Neurosci-
ences Institute in San Diego, Professor Mandyam Srinivasan and Drs. Judith Reinhard and Charles 
Claudianos from the Research School of Biological Sciences at ANU, and neuropsychologists Professor 
Jason Mattingley and Associate Professors Ross Cunnington and Mark Bellgrove from the University of 
Melbourne. Collaboration between these groups has flourished since we relocated to the new QBI build-
ing, with joint programmes being developed based on common behavioural assays that can be applied 
in organisms as diverse as Drosophila through to humans. Discoveries from these groups are providing 
new insights into the mechanisms regulating how attention is directed during learning. Meanwhile the 
Srinivasan group is revolutionising our concepts of optic flow during flight, navigation and distance 
measurement based on knowledge obtained from the visual-motor system in honeybees. Similarly, 
work on the visual system from Professors David Vaney and Justin Marshall’s laboratories are revealing 
the fundamental retinal pathways that mediate vision in a variety of animal models.
 Another key area we identified as integral to our success is computational neuroscience. Driven 
by Professor Goodhill, our ability to construct testable computational models of plasticity is beginning 
to complement much of our research. The awarding of one of only three multi-million dollar ARC/
NHMRC five year special research initiative Thinking Systems grants has allowed us to expand our 
capabilities in this area and foster numerous productive collaborations with computational scientists. 
This exciting development is already providing new insights into hippocampal and amygdala learning 
at the neuronal and systems levels.
 Another large five year ARC grant with Professor Max Lu from the Australian Institute of 
Bioengineering and Nanotechnology and Professor Dongyuan Zhau from Fudan University has seen 
us establish one of the first groups in the area of Nano-Neuroscience, with Associate Professor Helen 
Cooper as the lead biologist. Already this has led to the development of nanoparticles to deliver drugs 
BARTLETT ❖ QUEENSLAND BRAIN INSTITUTE: GROWTH AND DIRECTION 136
across the blood-brain barrier, a key advance that has both therapeutic and research applications. We 
are also investigating nanotechnology-inspired approaches to molecular magnetic resonance imaging 
(MRI) and brain recording and stimulation, the latter opening up the exciting possibility of developing 
nanoelectrodes to stimulate and record from large numbers of synapses at the one time, thereby creating 
a more complete picture of how networks influence behaviour.
 More recently, we have expanded our research capacity by fostering the experimental programmes 
of a number of outstanding basic and clinical neuroscientists exploring the genetic basis of disease 
susceptibility. These include Professors Bryan Mowry, and John McGrath, Dr. Darryl Eyles and Dr. Tom 
Burne (schizophrenia), Dr. Tim Bredy (epigenetic basis of anxiety-related disorders), Associate Professor 
Mark Bellgrove (autism and ADHD), Dr. Robyn Wallace (MND and epilepsy), Professor David Reutens 
(epilepsy and stroke) and Professor Linda Richards (developmental brain disorders). The addition of 
psychiatrists and neurologists to the faculty has also enhanced the potential for clinical translation. In 
this regard I am particularly pleased that two of our early discoveries are nearing the clinical phase for 
treatment of spinal cord injury and multiple sclerosis, and that we hold many patents related to other 
neurodegenerative conditions, including ageing dementia and Alzheimer’s disease.
 To give us a competitive edge in this field we have also recently formed an alliance with the 
Second Military Medical University to establish a Neurogenetics laboratory in Shanghai, which will 
allow us to recruit large cohorts of patients for genotyping and possible future clinical trials. To facilitate 
this initiative we have appointed the Clinical Director in the Changzheng Hospital, Professor Huji Xu, to 
the faculty of QBI. This development also coincides with major advances in gene sequencing technology 
which now enable us to perform gene-sequencing including epigenetic sequencing, very rapidly and 
in fine detail. In order to ensure we are able to advance as quickly as possible in this competitive area, 
we are currently installing an Illumina next generation sequencer. As an example of how the animal 
models are complementing this research, we are now using Drosophila to explore the function of genes 
identified in these human screens, as the powerful genetics of this model allows us to rapidly link genes 
to behaviour and disease. Our capabilities in this area have been expanded by the forging of strong 
collaborative links with the Chinese Academy of Science’s Institute of Biophysics (IBP) in Beijing, which 
hosts a world- renowned Drosophila group headed by Professors Aike Guo and Li Liu. We recently 
received three million dollars in an NIRAP grant to facilitate the establishment of a joint laboratory with 
the IBP, which we believe places us and Queensland at the forefront of the burgeoning Chinese research 
endeavour in biological sciences.
 However, one undeniable truth of modern neuroscience is that maintaining a leading research 
profile requires a significant investment in providing the best technology available. In addition to our 
recruitment strategy we therefore also acknowledged the importance of infrastructure support, begin-
ning with the establishment of the world’s largest and best neuroscience-dedicated flow cytometry facil-
ity, an advanced microscopy suite, and a behavioural facility. However, of primacy in this regard was 
our belief that QBI would have to establish advanced imaging technologies such as MRI and positron 
emission tomography (PET) if we were to be able to translate our findings and test hypothesis directly. 
This has taken considerable effort, but has ultimately resulted in the creation of a Centre for Advanced 
Imaging to be housed in a new purpose-built $50,000,000 building in the same precinct as QBI. We are 
also delighted to have recruited as the Centre’s inaugural Director Professor David Reutens, previously 
Director of Neurology and Professor of Neurosciences at Monash University, and through intensive 
grant applications have successfully obtained funding for a suite of imaging technology second to none, 
which includes 16.4T and 9.4T MRI scanners and a PET/MRI system for animal studies, as well as 7T, 
4T, and 3T MRI scanners for human research.
 In summary, the recruitment of a highly talented and well-resourced team of neuroscientists 
has underpinned our success, exemplified by our peerless grant and fellowship success. However, this 
level of achievement could not have been attained without the generous and farsighted support I have 
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received from many parties since arriving from Melbourne in 2002. A confluence of foresight by three 
major Queensland figures, Premier Peter Beattie, Vice-Chancellor Professor John Hay and philanthro-
pist extraordinaire Mr. Chuck Feeney delivered the $65,000,000 required to build the QBI. Wonderfully 
designed by the gifted architect John Wardle, it was opened by Premier Anna Bligh in October 2007 who 
announced a further $25,000,000 to support our operations. The current Vice-Chancellor, Professor Paul 
Greenfield, has continued with visionary support and the QBI has been enormously lucky to have the 
support of several high-profile community figures such as David Merson, Sallyanne Atkinson, and Jeff 
Maclean, and philanthropists Peter Goodenough and Ross Maclean, amongst many others. I hope and 
believe these investments and support have already returned significant economic benefit to the people 
of Queensland, but that this return pales beside the contribution that our scientific discoveries will make 
to health and education of the people of Queensland over the coming years.
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